Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Author: Lisa Levin | November 20, 2023 03:35pm

Shares of ReNew Energy Global Plc (NASDAQ:RNW) gained during Monday’s session following strong quarterly sales.

ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.

ReNew Energy raised its FY24 adjusted EBITDA guidance to INR 62 billion - INR 66 billion.

ReNew Energy Global gained 13.6% to $6.74 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Bruush Oral Care Inc. (NASDAQ:BRSH) shares jumped 147.2% to $0.4179. Brüush received Nasdaq notification regarding minimum bid requirements.
  • Cuentas Inc. (NASDAQ:CUEN) shares gained 59% to $1.5098 after reporting a narrower quarterly loss.
  • Altamira Therapeutics Ltd. (NASDAQ:CYTO) jumped 52% to $0.4280. Altamira Therapeutics recently entered into a binding agreement for the sale of a 51% stake in its subsidiary Altamira Medica AG.
  • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) gained 41.4% to $1.4000. Cardio Diagnostics Holdings announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the American Heart Association.
  • YPF Sociedad Anónima (NYSE:YPF) shares climbed 40.8% to $15.11. Javier Milei‘s victory in Argentina’s presidential election sparked a rally in Argentine ADRs trading on major U.S. stock exchanges.
  • GD Culture Group Limited (NASDAQ:GDC) rose 26.8% to $4.3074. GD Culture Group unveiled its transformative and photorealistic AI-driven digital human technology on TikTok.
  • Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 26.8% to $0.1752 after jumping 18% on Friday. Blue Star Foods recently signed a 2-year bid award purchase agreement with Sysco Corporation.
  • MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) gained 25.3% to $4.2729. MIRA Pharmaceuticals announced exclusive licensing agreement for oral ketamine analog, Ketamir-2.
  • Grupo Financiero Galicia S.A. (NASDAQ:GGAL) rose 25% to $15.63 after gaining 5% on Friday.
  • Transportadora de Gas del Sur S.A. (NYSE:TGS) shares climbed 23.1% to $12.88 after gaining over 4% on Friday.
  • Central Puerto S.A. (NYSE:CEPU) climbed 23.1% to $7.58.
  • Pampa Energía S.A. (NYSE:PAM) gained 23% to $45.60.
  • Transportadora de Gas del Sur S.A. (NYSE:TGS) rose 22.6% to $12.82 after gaining over 4% on Friday.
  • Banco BBVA Argentina S.A. (NYSE:BBAR) gained 22.4% to $5.40.
  • LogicMark, Inc. (NASDAQ:LGMK) shares rose 22.2% to $2.04. LogicMark recently posted GAAP loss of $1.10 per share for the third quarter.
  • IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) gained 20.3% to $7.79.
  • Telecom Argentina S.A. (NYSE:TEO) climbed 19.4% to $6.40 after gaining around 4% on Friday.
  • Banco Macro S.A. (NYSE:BMA) gained 17.1% to $23.71.
  • HireRight Holdings Corporation (NYSE:HRT) jumped 17.4% to $11.81 after gaining 5% on Friday.
  • Yoshiharu Global Co. (NASDAQ:YOSH) shares climbed 15.7% to $0.4050. The company recently reported an increase in quarterly sales.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 15.6% to $17.00.
  • MediciNova, Inc. (NASDAQ:MNOV) rose 15.2% to $2.0508. The company announced new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma presented at the 28th Annual Meeting of the Society for Neuro-Oncology.
  • Kronos Bio, Inc.(NASDAQ:KRON) gained 14.4% to $1.2699. Kronos recently posted downbeat quarterly results.
  • Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA) gained 14.4% to $6.80.
  • Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) rose 13.6% to $5.74. Goldman Sachs initiated coverage on Iovance Biotherapeutics with a Buy rating and announced a price target of $12.
  • Anavex Life Sciences Corp. (NASDAQ:AVXL) jumped 11.8% to $7.01. The clinical-stage biopharmaceutical company announced that it initiated a regulatory submission with the European Medicines Agency (EMA).
  • Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 11.7% to $31.42. Intellia Therapeutics recently announced it received European Union orphan drug designation for NTLA-2002.
  • XPeng Inc. (NYSE:XPEV) gained 9% to $18.30.
  • Motus GI Holdings, Inc. (NASDAQ:MOTS) gained 7.6% to $3.98 after declining around 5% on Friday. Motus GI recently announced the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance.
  • NIO Inc. (NYSE:NIO) fell 6.2% to $7.85. Nio announced on Sunday that it has activated its 2,100th power swap station.
  • Coinbase Global, Inc. (NASDAQ:COIN) gained 4.2% to $103.12.

Losers

  • NanoString Technologies, Inc. (NASDAQ:NSTG) shares fell 46% to $0.69. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.
  • PaxMedica, Inc. (NASDAQ:PXMD) fell 40.6% to $1.04 after the company announced pricing of $7 million public offering of 5,384,615 shares and accompanying warrants at a price of $1.30 per unit.
  • Safe and Green Development Corporation (NASDAQ:SGD) fell 25.5% to $3.14. Safe And Green Development shares jumped 39% on Friday after the company said it does not intend to conduct the offering of the shares of common stock contemplated by the Registration Statement.
  • Alzamend Neuro, Inc. (NASDAQ:ALZN) dipped 25% to $1.2400. Alzamend Neuro received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for major depressive disorder (MDD).
  • Yatsen Holding Limited (NYSE:YSG) fell 24.2% to $0.6559. Yatsen Holding is expected to release its unaudited financial results for the third quarter on Nov. 21, 2023.
  • 2seventy bio, Inc. (NASDAQ:TSVT) declined 16.4% to $1.78. The FDA's Oncologic Drugs Advisory Committee (ODAC) will meet to review data supporting the supplemental Biologics License Application (sBLA) for Abecma (idecabtagene vicleucel) for earlier lines of triple-class exposed relapsed or refractory multiple myeloma (RRMM) based on results from the pivotal Phase 3 KarMMa-3 study.
  • Allurion Technologies Inc. (NYSE:ALUR) fell 12.6% to $3.72.
  • Safe & Green Holdings Corp. (NASDAQ:SGBX) shares fell 12.6% to $0.6821 after gaining around 7% on Friday. Safe & Green Holdings recently posted a narrower-than-expected quarterly loss.
  • Greenland Technologies Holding Corporation (NASDAQ:GTEC) declined 12.5% to $2.87 following weak quarterly results.
  • reAlpha Tech Corp. (NASDAQ:AIRE) declined 10.5% to $8.40. ReAlpha Tech filed a prospectus for the offering of up to 1.67 million common units at a price of $12 per unit.
  • Applied UV, Inc. (NASDAQ:AUVI) shares fell 9.4% to $0.1340 after the company reported third-quarter results.
  • MGO Global, Inc. (NASDAQ:MGOL) shares fell 9.1% to $0.50 after jumping over 10% on Friday. MGO Global recently posted a wider third-quarter loss.
  • Genelux Corporation (NASDAQ:GNLX) declined 8.7% to $10.83.
  • Tharimmune, Inc. (NASDAQ:THAR) shares fell 8.6% to $0.1922. Tharimmune shares climbed around 17% on Friday after the company announced a 1-for-25 reverse stock split.
  • Chegg, Inc. (NYSE:CHGG) fell 8.2% to $9.60. Morgan Stanley downgraded Chegg from Equal-Weight to Underweight and lowered the price target from $10 to $9.

Now Read This: This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Posted In: AIRE ALUR ALZN AUVI AVXL BBAR BMA BRSH BSFC CDIO CEPU CHGG COIN CUEN CYTO GDC GGAL GNLX GTEC GYRE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist